Science 5 July 1985: Vol. 229. no. 4708, pp. 74 - 77 DOI: 10.1126/science.2990041

Prev | Table of Contents | Next

Articles

Robust Growth of Human Immunodeficiency Virus Type 1 (HIV-1).

H. Kim and J. Yin (2005)
Biophys. J. 89, 2210-2221
 |  Abstract »  |  Full Text »  |  PDF »

Granulin and Granulin Repeats Interact with the Tat{middle dot}P-TEFb Complex and Inhibit Tat Transactivation.

M. Hoque, B. Tian, M. B. Mathews, and T. Pe'ery (2005)
J. Biol. Chem. 280, 13648-13657
 |  Abstract »  |  Full Text »  |  PDF »

Interaction of the Protein Transduction Domain of HIV-1 TAT with Heparan Sulfate: Binding Mechanism and Thermodynamic Parameters.

A. Ziegler and J. Seelig (2004)
Biophys. J. 86, 254-263
 |  Abstract »  |  Full Text »  |  PDF »

Monocytes Treated with Human Immunodeficiency Virus Tat Kill Uninfected CD4+ Cells by a Tumor Necrosis Factor-Related Apoptosis-Induced Ligand-Mediated Mechanism.

Y. Yang, I. Tikhonov, T. J. Ruckwardt, M. Djavani, J. C. Zapata, C. D. Pauza, and M. S. Salvato (2003)
J. Virol. 77, 6700-6708
 |  Abstract »  |  Full Text »  |  PDF »

Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline.

B. O. Kim, Y. Liu, Y. Ruan, Z. C. Xu, L. Schantz, and J. J. He (2003)
Am. J. Pathol. 162, 1693-1707
 |  Abstract »  |  Full Text »  |  PDF »

RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication.

R. M. Surabhi and R. B. Gaynor (2002)
J. Virol. 76, 12963-12973
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.

G. Barillari and B. Ensoli (2002)
Clin. Microbiol. Rev. 15, 310-326
 |  Abstract »  |  Full Text »  |  PDF »

Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator Sequences.

C. F. Bourgeois, Y. K. Kim, M. J. Churcher, M. J. West, and J. Karn (2002)
Mol. Cell. Biol. 22, 1079-1093
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Interactions Involved in the Transactivation of the Human T-Cell Leukemia Virus Type 1 Promoter Mediated by Tax and CREB-2 (ATF-4).

F. Gachon, S. Thebault, A. Peleraux, C. Devaux, and J.-M. Mesnard (2000)
Mol. Cell. Biol. 20, 3470-3481
 |  Abstract »  |  Full Text »

Molecular Cloning of a Novel Human I-mfa Domain-containing Protein That Differently Regulates Human T-cell Leukemia Virus Type I and HIV-1 Expression.

S. Thebault, F. Gachon, I. Lemasson, C. Devaux, and J.-M. Mesnard (2000)
J. Biol. Chem. 275, 4848-4857
 |  Abstract »  |  Full Text »  |  PDF »

The Human Immunodeficiency Virus Type 1 Tat Protein Up-Regulates the Promoter Activity of the Beta-Chemokine Monocyte Chemoattractant Protein 1 in the Human Astrocytoma Cell Line U-87 MG: Role of SP-1, AP-1, and NF-kappa B Consensus Sites.

S. P. Lim and A. Garzino-Demo (2000)
J. Virol. 74, 1632-1640
 |  Abstract »  |  Full Text »

Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases.

B.-W. Park, D. M. O'Rourke, Q. Wang, J. G. Davis, A. Post, X. Qian, and M. I. Greene (1999)
PNAS 96, 6434-6438
 |  Abstract »  |  Full Text »  |  PDF »

Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-{alpha}-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells.

K. E. Traber, H. Okamoto, C. Kurono, M. Baba, C. Saliou, T. Soji, L. Packer, and T. Okamoto (1999)
Int. Immunol. 11, 143-150
 |  Abstract »  |  Full Text »  |  PDF »

Transactivation of a Ribosomal Gene by Simian Virus 40 Large-T Antigen Requires at Least Three Activities of the Protein.

J. F. Cavender, C. Mummert, and M. J. Tevethia (1999)
J. Virol. 73, 214-224
 |  Abstract »  |  Full Text »  |  PDF »

Naturally Occurring Human Immunodeficiency Virus Type 1 Long Terminal Repeats Have a Frequently Observed Duplication That Binds RBF-2 and Represses Transcription.

M. C. Estable, B. Bell, M. Hirst, and I. Sadowski (1998)
J. Virol. 72, 6465-6474
 |  Abstract »  |  Full Text »  |  PDF »

The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists.

M. Rusnati, G. Tulipano, C. Urbinati, E. Tanghetti, R. Giuliani, M. Giacca, M. Ciomei, A. Corallini, and M. Presta (1998)
J. Biol. Chem. 273, 16027-16037
 |  Abstract »  |  Full Text »  |  PDF »

PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo.

M. O. Gold, X. Yang, C. H. Herrmann, and A. P. Rice (1998)
J. Virol. 72, 4448-4453
 |  Abstract »  |  Full Text »  |  PDF »

Genomic Organization and Functional Characterization of the Chemokine Receptor CXCR4, a Major Entry Co-receptor for Human Immunodeficiency Virus Type 1.

S. A. Wegner, P. K. Ehrenberg, G. Chang, D. E. Dayhoff, A. L. Sleeker, and N. L. Michael (1998)
J. Biol. Chem. 273, 4754-4760
 |  Abstract »  |  Full Text »  |  PDF »

HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein beta  (NF-IL6) Transcription Factors.

C. Ambrosino, M. R. Ruocco, X. Chen, M. Mallardo, F. Baudi, S. Trematerra, I. Quinto, S. Venuta, and G. Scala (1997)
J. Biol. Chem. 272, 14883-14892
 |  Abstract »  |  Full Text »  |  PDF »

Interaction of HIV-1 Tat Protein with Heparin. ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE.

M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'A. di Fagagna, M. Giacca, and M. Presta (1997)
J. Biol. Chem. 272, 11313-11320
 |  Abstract »  |  Full Text »  |  PDF »

The Tat Protein of Human Immunodeficiency Virus Type 1Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR.

S. R. Brand, R. Kobayashi, and M. B. Mathews (1997)
J. Biol. Chem. 272, 8388-8395
 |  Abstract »  |  Full Text »  |  PDF »

A simple method for measurement of cell-substrate attachment forces: application to HIV-1 Tat.

L. Channavajjala, A Eidsath, and W. Saxinger (1997)
J. Cell Sci. 110, 249-256
 |  Abstract »  |  PDF »

Repression of MHC class I gene promoter activity by two-exon Tat of HIV.

T. Howcroft, K Strebel, M. Martin, and D. Singer (1993)
Science 260, 1320-1322
 |  Abstract »  |  PDF »

HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors..

H Kato, H Sumimoto, P Pognonec, C H Chen, C A Rosen, and R G Roeder (1992)
Genes & Dev. 6, 655-666
 |  Abstract »  |  PDF »

Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition..

B J Calnan, S Biancalana, D Hudson, and A D Frankel (1991)
Genes & Dev. 5, 201-210
 |  Abstract »  |  PDF »

Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation..

M F Laspia, A P Rice, and M B Mathews (1990)
Genes & Dev. 4, 2397-2408
 |  Abstract »  |  PDF »

A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator.

P Nelbock, P. Dillon, A Perkins, and C. Rosen (1990)
Science 248, 1650-1653
 |  Abstract »  |  PDF »

Secondary structure is the major determinant for interaction of HIV rev protein with RNA.

H. Olsen, P Nelbock, A. Cochrane, and C. Rosen (1990)
Science 247, 845-848
 |  Abstract »  |  PDF »

Differential effects of nef on HIV replication: implications for viral pathogenesis in the host.

C Cheng-Mayer, P Iannello, K Shaw, P. Luciw, and J. Levy (1989)
Science 246, 1629-1632
 |  Abstract »  |  PDF »

Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat..

M J Selby, E S Bain, P A Luciw, and B M Peterlin (1989)
Genes & Dev. 3, 547-558
 |  Abstract »  |  PDF »

Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR.

N Ahmad and S Venkatesan (1988)
Science 241, 1481-1485
 |  Abstract »  |  PDF »

Virus-specific splicing inhibitor in extracts from cells infected with HIV-1.

D Gutman and C. Goldenberg (1988)
Science 241, 1492-1495
 |  Abstract »  |  PDF »

Regulation of HIV and HTLV gene expression..

H Varmus (1988)
Genes & Dev. 2, 1055-1062
 |  PDF »

Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters..

K A Jones, P A Luciw, and N Duchange (1988)
Genes & Dev. 2, 1101-1114
 |  Abstract »  |  PDF »

Tat protein from human immunodeficiency virus forms a metal-linked dimer.

A. Frankel, D. Bredt, and C. Pabo (1988)
Science 240, 70-73
 |  Abstract »  |  PDF »

A quantitative bioassay for HIV-1 based on trans-activation.

B. Felber and G. Pavlakis (1988)
Science 239, 184-187
 |  Abstract »  |  PDF »

Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis.

D. Knight, F. Flomerfelt, and J Ghrayeb (1987)
Science 236, 837-840
 |  Abstract »  |  PDF »

Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

W. Farmerie, D. Loeb, N. Casavant, C. Hutchison 3rd, M. Edgell, and R Swanstrom (1987)
Science 236, 305-308
 |  Abstract »  |  PDF »

Expression and characterization of the trans-activator of HTLV-III/LAV virus.

C. Wright, B. Felber, H Paskalis, and G. Pavlakis (1986)
Science 234, 988-992
 |  Abstract »  |  PDF »

Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

A. Fisher, L Ratner, H Mitsuya, L. Marselle, M. Harper, S Broder, R. Gallo, and F Wong-Staal (1986)
Science 233, 655-659
 |  Abstract »  |  PDF »

Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression.

W. Greene, W. Leonard, Y Wano, P. Svetlik, N. Peffer, J. Sodroski, C. Rosen, W. Goh, and W. Haseltine (1986)
Science 232, 877-880
 |  Abstract »  |  PDF »

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

K. Jones, J. Kadonaga, P. Luciw, and R Tjian (1986)
Science 232, 755-759
 |  Abstract »  |  PDF »

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

T. Lee, J. Coligan, J. Allan, M. McLane, J. Groopman, and M Essex (1986)
Science 231, 1546-1549
 |  Abstract »  |  PDF »

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

J Sodroski, W. Goh, C Rosen, A Tartar, D Portetelle, A Burny, and W Haseltine (1986)
Science 231, 1549-1553
 |  Abstract »  |  PDF »

Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

D Zagury, J Bernard, R Leonard, R Cheynier, M Feldman, P. Sarin, and R. Gallo (1986)
Science 231, 850-853
 |  Abstract »  |  PDF »

Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products.

R Hen, E Borrelli, and P Chambon (1985)
Science 230, 1391-1394
 |  Abstract »  |  PDF »

A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

J. Allan, J. Coligan, T. Lee, M. McLane, P. Kanki, J. Groopman, and M Essex (1985)
Science 230, 810-813
 |  Abstract »  |  PDF »

Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes.

A. Rabson, D. Daugherty, S Venkatesan, K. Boulukos, S. Benn, T. Folks, P Feorino, and M. Martin (1985)
Science 229, 1388-1390
 |  Abstract »  |  PDF »

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

S. Arya, C Guo, S. Josephs, and F Wong-Staal (1985)
Science 229, 69-73
 |  Abstract »  |  PDF »

To Advertise   |   Find Products